Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67

Publisher： Karger

E-ISSN： 1423-0291|80|5|219-227

ISSN： 1015-2008

Source： Pathobiology, Vol.80, Iss.5, 2013-04, pp. : 219-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Intra- and Interobserver Reproducibility Analysis of the Ki-67 Proliferation Marker Assessment on Core Biopsies of Breast Cancer Patients and Its Potential Clinical Implications

By  

Pathobiology, Vol. 80, Iss. 3, 2012-12 ,pp. : 111-118

Karger

Access to resources Recommend Favorite

BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters?

By  

Pathobiology, Vol. 83, Iss. 1, 2015-11 ,pp. : 1-12

Karger

Access to resources Recommend Favorite

Expression of RUNX3 Gene, Methylation Status and Clinicopathological Significance in Breast Cancer and Breast Cancer Cell Lines

By  

Pathobiology, Vol. 75, Iss. 4, 2008-06 ,pp. : 244-251

Karger

Access to resources Recommend Favorite

TP53 Status and Response to Chemotherapy in Breast Cancer

By  

Pathobiology, Vol. 75, Iss. 2, 2008-06 ,pp. : 132-139

Karger

Access to resources Recommend Favorite

High Apoptotic Index Correlates to p21 and p27 Expression Indicating a Favorable Outcome of Primary Breast Cancer Patients, but Lacking Prognostic Significance in Multivariate Analysis

By  

Pathobiology, Vol. 71, Iss. 4, 2004-07 ,pp. : 217-222

Karger

Access to resources Recommend Favorite